Drug and chemotherapy shrink pancreatic cancer tumors in over 60%

Among 61 people with pancreatic cancer that had spread who received daraxonrasib and chemotherapy, around 8% had no detectable tumor on CT scans. Doctors say the early results do not establish a cure or a survival benefit.
In this article
Just over 60% of 61 people with recently diagnosed pancreatic cancer that had spread saw their tumors shrink or disappear after receiving daraxonrasib with chemotherapy, the BBC said. Around 8% had tumors that became undetectable on CT scans, and tumors stopped growing in 90% of participants.
Chemotherapy can shrink advanced pancreatic tumors, but the cancer often grows again. Doctors say it is too early to know how long the combination might keep the disease at bay or whether it helps patients live longer.
Why longer follow-up matters
Daraxonrasib is a KRAS inhibitor, a drug that targets a type of signal involved in cancer growth. It acts on RAS mutations found in most pancreatic cancers. The drug has been approved in the US; the early trial studied it in combination with chemotherapy.
The trial followed patients for a year and a half on average, and some did not see their cancer return during that time. Cancer Research UK researcher Sam Godfrey said a scan showing no cancer does not mean a patient is necessarily cancer-free: the disease can return, so more time is needed.
Dr Wungki Park of Memorial Sloan Kettering Cancer Center, who is involved in the trial, said the responses and longer disease control might eventually translate into longer survival. The results were being presented at the EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics in Barcelona, held 18–20 November 2026. Longer studies are needed to establish how durable the responses are and whether they improve survival.
Follow AveNews
Earlier in Science
HealthMalaria antibody protects Mali infants but lowers R21 response in study
Researchers found L9LS was 78% effective against parasite infection in Malian infants, but those given it before the R21 vaccine had 20% to 30% lower vaccine-induced antibody levels.
2 min
Physics, Maths & DiscoveriesArchaeologists found about 3 Maya sculptures at El Mirador in 2026
The new stucco finds in Guatemala need restoration. They add to a collection of earlier heads that researchers say offers a rare view of Maya artistry.
2 min
SpaceRelativity Space fires Terran R stage for over 400 seconds
The first-flight second stage completed its ground test on the first attempt, and Relativity has finished structural qualification testing of the rocket’s primary structures.
3 min
